Dr. Bo-Shiun Lai's Credentials

Accepting New Patients

Yes, this doctor is accepting new patients

Biography

Dr. Bo-Shiun Lai is a physician-scientist based in Vancouver, British Columbia. His clinical work includes general family medicine, HIV & hepatitis C management in primary care, and treatment of menopause symptoms. His research led to both the development of a novel therapy against toxoplasmosis and deepening understanding of host immune response. His work resulted in a United States patent and a nomination for the Cozzarelli Prize, awarded annually by the National Academy of Sciences. Dr. Lai obtained his Doctor of Philosophy (PhD) in 2017 from the University of Cambridge, where he was a recipient of the prestigious, full-ride Gates Cambridge Scholarship. He received his Doctor of Medicine (MD) from the world-renowned Johns Hopkins School of Medicine in 2021. He completed training in family medicine in 2023 at the University of Toronto. His hobbies include swimming, photography, and traveling. Above all else, he loves spending time with the love of his life, Jennifer. Note: All comments posted must adhere to RateMD's Terms of Use. Any feedback in violation will be flagged for removal. Thank you for your cooperation.

Languages

• Mandarin
• English

Education

• Johns Hopkins University (Grad. 2021)
• University of Cambridge (Grad. 2017)

Areas of Expertise

• Menopause and Hormone Replacement Therapy
• Adult Preventive Care
• Basic Dermatology
• Hepatitis C
• Osteoarthritis and Osteoporosis
• High Cholesterol (hyperlipidemia)
• Diabetes & Hypertension
• Allergy & Asthma Treatment
• Adult Medicine, Atherosclerosis, Diabetes And More
• COPD
• Aids/hiv, Infections, Immunizations And More

Awards & Recognitions

• Medical Innovators Development Program (353,000 CAD), Vanderbilt University School of Medicine
• Cambridge International Scholarship ($223,000 CAD), Cambridge Overseas Trust, Cambridge, England
• Gates Cambridge Scholarship (Full Scholarship; $277,000 CAD), The Bill & Melinda Gates Foundation, Seattle, WA
• Nomination for the Cozzarelli Prize in Biomedical Sciences, National Academy of Sciences USA, Washington, DC

Publications & Research

• Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies
• Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries
• Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase
• Conjugate constructs, delivery, and use for treatment of disease
• Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections
• Recent advances in aptamer discovery and applications
• Deactivation and mislocalization of Toxoplasma gondii rhoptry protein 18 induced by a single amino acid mutation on the proton transport catalytic aspartic acid
• Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features
• Toxoplasma gondii secretory proteins and their role in invasion and pathogenesis
• Multilayer network analysis of miRNA and protein expression profiles in breast cancer patients
• Spiroindolone That Inhibits PfATPase4 Is a Potent, Cidal Inhibitor of Toxoplasma gondii Tachyzoites In Vitro and In Vivo
• Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii